Quantum Biopharma (QNTM) Net Income towards Common Stockholders Growth (3y) (2022 - 2026)
Quantum Biopharma (QNTM) Net Income towards Common Stockholders Growth (3y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Genmab A | 276,399.99 Bn | 276,398.47 Bn | 831.00 Mn | - |
| 2 | Akari Therapeutics | 1,217.26 Bn | 1,217.26 Bn | - | - |
| 3 | BeOne Medicines | 419.38 Bn | 414.59 Bn | 1.35 Bn | 38.43% |
| 4 | Vertex Pharmaceuticals | 126.54 Bn | 119.30 Bn | 2.59 Bn | 13.80% |
| 5 | Pharming | 110.17 Bn | 110.12 Bn | 65.80 Mn | - |
| 6 | Regeneron Pharmaceuticals | 64.97 Bn | 56.22 Bn | 3.31 Bn | -3.84% |
| 7 | Argenx Se | 56.44 Bn | 56.44 Bn | 1.18 Bn | 144.84% |
| 8 | Alnylam Pharmaceuticals | 40.09 Bn | 37.08 Bn | 959.66 Mn | 47.10% |
| 9 | Revolution Medicines | 37.15 Bn | 37.15 Bn | - | - |
| 10 | Quantum Biopharma | 15.08 Mn | 8.50 Mn | - | -37,262.16% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -37,262.16% |
| Mar 31, 2025 | -168.21% |
| Jun 30, 2024 | 25.99% |
| Mar 31, 2024 | -25.99% |
| Sep 30, 2023 | 25.99% |
| Jun 30, 2023 | 25.99% |
| Mar 31, 2023 | 99.34% |
| Mar 31, 2022 | 19.43% |